openPR Logo
Press release

Clinical Trial Management Systems Market: Key Players are Bioclinica, Bio-Optronics, Datatrak International, DSG, Inc., Forte Research Systems, Inc., Medidata Solutions, MedNet Solutions, Oracle, PAREXEL

08-02-2018 11:47 AM CET | Health & Medicine

Press release from:

Clinical Trial Management Systems Market

Clinical Trial Management Systems Market

With healthcare cost and patent cliff reaching new highs, clinical trial management systems (CTMS) market has witnessed a revolutionary transformation over the recent years, primarily in terms of operational model. As per estimates, global spending on medications is forecast to record more than USD 1 trillion by 2022. Almost a decade back, the expenditure was near about USD 885 billion. In the face of this sudden escalation, CTMS industry is apparently approaching new era of trial research that is more streamlined and patient centric. A plethora of off-beat innovations that the business space is presently characterized by can be placed as viable substantiation to the aforementioned fact.

Request for a sample of this research report @

In this regard, the latest scoop that is grabbing most of the headlines in clinical trial management systems industry is OmniComm Systems’ launch of TrialMaster Version 5. This breakthrough user-friendly solution for electronic data capture is claimed to be exceptionally featured with intuitive user interface, ePRO (electronic patient reported outcomes) capability, risk based monitoring tools and mobile friendly technology. Quite evidently coherent from its credentials, this enhanced version of TrialMaster EDC is likely to be a milestone innovation in CTMS market, making OmniComm Systems’ stance more pronounced in the competitive landscape.

Growth Drivers:
1. Outsourcing of clinical trials to emerging countries
2. Enhanced R&D expenditure of life science and clinical research industries
3. Increased number of clinical trials

Some of the major players of global CTMS market are Oracle Corporation, DATATRAK International, Merge Healthcare (IBM Watson), MedNet Solutions, Parexel International Corp., Forte Research Systems, Medidata Solutions and Omnicomm Systems.

Technological advancements are undeniably catapulting clinical trials into a new age of scientific breakthroughs, where the industry is slated to scale up the productivity spectrum with cost effective outcome-based approach. With huge influx of data in pharma space, the complexity of clinical trial management systems market is increasing. Amidst this backdrop, clinical trial management systems market players, as it is observed lately, have been showing great interest in big data analytics approach, enabling an efficient and fast track data collection, data security, and data management. The affluence of big data analytics is vividly coherent from the estimation that claims cloud based CTMS industry to witness a remarkable CAGR of 15% over 2017-2024.

Browse Full Report @

The advanced methodologies if incorporated into conventional randomized controlled trial (RCT) model are deemed to tackle a slew of limitations such as reproducibility, infrequent external validation, generalizability, and cost issues. Not to mention, with connected technologies such as machine learning, artificial intelligence, and cloud computing becoming mainstream, clinical trial management systems industry is set to witness a disruption of sorts over the ensuing years.

Yet another trend that is expected to leave an inexorable impact on CTMS marketplace is outsourcing of clinical research. As pharma players are constantly combating with the pricing pressure, outsourcing has turned out to be a smarter and innovative strategy. A multitude of factors are responsible for this growing dependence on clinical research outsourcing, capacity constraints being at the pinnacle. Reportedly, since 2007 renowned pharmaceutical behemoths including Merck, Pfizer, and AstraZeneca have underlined plans to downsize and consolidate their operations. While as of now CROs are offering preclinical as well as clinical services, they are soon expected to widen their spectrum into trial management projects.

About Fractovia: is one of leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.

Contact Us:

1968 S. Coast Hwy #586,
Laguna Beach CA 92651,

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management Systems Market: Key Players are Bioclinica, Bio-Optronics, Datatrak International, DSG, Inc., Forte Research Systems, Inc., Medidata Solutions, MedNet Solutions, Oracle, PAREXEL here

News-ID: 1158671 • Views: 731

More Releases from

Non-alcoholic Beer Market Key Players are Heineken, Suntory, Bernard Family Brew …
Owing to a worldwide escalation in the preference for low liquor content beverages, the non-alcoholic beer market size has proliferated at an outstanding pace over the past decade. This has been complemented with the fact that the disposable incomes among the global middle-class population have shot up which has further provided a commendable boost to the overall non-alcoholic beer industry. The rising consolidation and maturation of this business space can
Food Protein Ingredients Market key players are ADM, Cargill, DuPont, Bunge, Mea …
Food protein ingredients market has lately witnessed a profitable trajectory, pertaining to the changing relationship of consumers with food due to increasing urbanization and greater disposable incomes. Taking the rapidly increasing global populace into consideration, which incidentally according to the UN, will surpass 9.5 billion, it is rather obvious that consumption patterns will undergo an eventual change. With the changes that will follow in the dietary preferences, experts anticipate food
Food Enzymes Market Trends 2018 with Key Players of this Industry are BASF, DSM, …
Danish food enzymes market major Chr. Hansen, has recently announced that it will be expanding its West Allis plant that produces enzymes that are freeze-dried and shipped all over the world. The enzymes go into yogurt, cheese, and other food, as well as in animal feed, baby formula, probiotic supplements, and natural dyes. Allegedly, this latest expansion by Hansen to increase the production capacity and add new capabilities to its
Dental Osseointegration Implants Market Major Key Players are Zimmer Biomet, Str …
Having already experienced monetary returns from a slew of imperative collaborations since the last few years, osseointegration implants market has now observed yet another partnership that would help increase its overall remuneration. The reputed American producer of dental equipment consumables, Dentsply Sirona has recently announced a partnership with Zephyr Sleep Technologies. Request for a sample of this research report @ This alliance has been apparently aimed at generating potentially new

All 5 Releases

More Releases for Trial

Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Singapore Clinical Trial Market Analysis
Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials. The national government has been extremely supportive in developing clinical research activities and maintaining high immunization rates.
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical